Amarin reported $-28350000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amarin AMRN:US $ -28.35M 44.74M
Biocryst Pharmaceuticals BCRX:US $ -73.92M 58.39M
Epizyme EPZM:US $ -55.47M 4.84M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -64M 289M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Novartis NOVN:VX SF 3912M 230M
Teva Pharmaceutical Industries TEVA:US $ 766M 253M